NeuroPace, Inc. (NASDAQ:NPCE) is one of the 10 Best Brain-Computer Interface Stocks to Buy. On May 29, NeuroPace, Inc.
The ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) today announced completion of enrollment of 600 patients in the National Cancer Institute (NCI)-sponsored phase 2/3 trial EA6141. The randomized trial ...
A legacy of mentorship continues and expands: over three decades of Young Investigators of the Year; the Paul Carbone, MD Fellowship turns 20; and the Group honors its second Remarkable Mentor to ...
The MarketWatch News Department was not involved in the creation of this content. New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger ...
Participant Attitudes Toward an Intensive Trial of Multiple Biopsies, Multidimensional Molecular Analysis, and Reporting of Results in Metastatic Triple-Negative Breast Cancer Racial disparity in ...
Oncology physicians' knowledge, attitudes, and practices regarding fertility preservation. Background: The ECOG PS scale is a widely used measure of functional status in oncology and is a good ...
New AI models integrating imaging, clinical, and molecular data from the TAILORx tissue biorepository show stronger prognostic performance than current methods to predict recurrence risk in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results